Inventiva (IVA) Net Cash Flow (2019 - 2025)
Inventiva (IVA) recorded quarterly Net Cash Flow of -$88.9 million in Q2 2025, down 70.74% quarter-over-quarter from -$52.1 million in Q2 2024, and down 70.74% on a YoY basis from -$303.8 million in Q2 2024.
Inventiva (IVA) Net Cash Flow (2019 - 2025) Analysis & Trends
Inventiva's Net Cash Flow history runs 6 years deep, the most recent figure standing at -$88.9 million for Q2 2025.
- In Q2 2025, Net Cash Flow fell 70.74% year-over-year to -$88.9 million; the TTM figure through Dec 2025 stood at -$140.9 million (down 170.74% YoY), while the FY2025 annual figure was $3.8 million, down 94.86% from the prior year.
- Net Cash Flow was -$88.9 million for Q2 2025 at Inventiva, down from -$52.1 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of -$1.7 million in Q1 2021 to a low of -$88.9 million in Q2 2025.
- Historically, Net Cash Flow has averaged -$28.9 million across 4 years, with a median of -$16.4 million in 2021.
- The sharpest annual moves came in 2021 and 2022: Net Cash Flow plunged 332.96% in 2021, then gained 25.56% in 2022.
- A 4-year view of Net Cash Flow shows it stood at -$17.2 million in 2021, then increased by 25.56% to -$12.8 million in 2022, then slumped by 307.0% to -$52.1 million in 2024, then tumbled by 70.74% to -$88.9 million in 2025.
- The last three Net Cash Flow figures came in at -$88.9 million (Q2 2025), -$52.1 million (Q2 2024), and -$12.8 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 664,983.53 |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -88.89 Mn |
| Jun 30, 2025 | -88.89 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Dec 31, 2022 | -12.79 Mn |
| Dec 31, 2022 | -12.79 Mn |
| Sep 22, 2022 | -13.08 Mn |
| Sep 22, 2022 | -13.08 Mn |
| Dec 31, 2021 | -17.18 Mn |
| Dec 31, 2021 | -17.18 Mn |
| Jun 30, 2021 | -16.38 Mn |
| Jun 30, 2021 | -16.38 Mn |
| Mar 31, 2021 | -1.72 Mn |
| Mar 31, 2021 | -1.72 Mn |
| Dec 31, 2020 | 19.59 Mn |
| Dec 31, 2020 | 19.59 Mn |
| Jun 30, 2020 | 7.03 Mn |
| Jun 30, 2020 | 7.03 Mn |
| Mar 31, 2020 | 12.20 Mn |
| Mar 31, 2020 | 12.20 Mn |